# Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

> **NCT02934477** · — · RECRUITING · sponsor: **Center for International Blood and Marrow Transplant Research** · enrollment: 650 (estimated)

## Conditions studied

- Myelofibrosis

## Interventions

- **OTHER:** Hematopoietic Stem Cell Transplant

## Key facts

- **NCT ID:** NCT02934477
- **Lead sponsor:** Center for International Blood and Marrow Transplant Research
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-11
- **Primary completion:** 2026-11
- **Final completion:** 2027-10
- **Target enrollment:** 650 (ESTIMATED)
- **Last updated:** 2023-08-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02934477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02934477, "Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02934477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*